Concord Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has submitted a compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended December 31, 2025. This is a routine filing required under SEBI's Depositories Regulations to confirm that any dematerialisation requests received during the quarter were properly processed. Importantly, the RTA has noted that it did not receive any requests for dematerialisation or rematerialisation of shares during this quarter. The certificate also confirms that where applicable, security certificates were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's member register within the prescribed timelines.
This is a standard quarterly compliance filing with no material impact on shareholders or the stock price. It simply confirms the absence of any share demat/remat activity during the quarter and affirms that the company's share records are in good order.